Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Trial    crawled date : 2021 - 11 - 01    save search

Global Ion Exchange Resins Markets, 2021-2026 - Water-Guzzling Industrial Units and Increasing Emphasis on Sustainable Wastewater Treatment Benefit Demand
Published: 2021-11-01 (Crawled : 22:00) - prnewswire.com
BIO | $278.21 -2.48% 0.0% 210K twitter stocktwits trandingview |
Health Technology
| | O: 0.75% H: 0.74% C: -1.39%

treatment ema trial
Raytheon Technologies CFO to present at Baird's 2021 Virtual Global Industrial Conference
Published: 2021-11-01 (Crawled : 21:00) - prnewswire.com
GIC | $40.96 -0.82% 0.0% 57K twitter stocktwits trandingview |
Retail Trade
| | O: 5.42% H: 0.0% C: 0.0%
RTX | $101.02 -0.36% -0.22% 7.7M twitter stocktwits trandingview |
Electronic Technology
| | O: -0.02% H: 0.32% C: -0.82%

trial conference
Oil-Dri Announces Price Increases on Industrial Clay and Synthetic Absorbents
Published: 2021-11-01 (Crawled : 21:00) - globenewswire.com
ODC | $69.43 -1.64% 0.0% 22K twitter stocktwits trandingview |
Process Industries
| | O: -0.3% H: 0.55% C: 0.24%

trial
Calithera Presents Interim Data from Phase 1b Trial of Arginase Inhibitor CB-280 in Cystic Fibrosis at NACFC 2021
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
CALA | $0.029 150.0% 580 twitter stocktwits trandingview |
Health Technology
| | O: 2.07% H: 3.55% C: 1.52%

fibrosis phase 1 phase 1b trial phase 2b cystic fibrosis
Cabaletta Bio Reports Clinical Data from the Third Dose Cohort in DesCAARTes™ Trial in Patients with mPV
Published: 2021-11-01 (Crawled : 19:00) - biospace.com/
CABA | $12.94 -2.85% -2.94% 930K twitter stocktwits trandingview |
Health Technology
| | O: 3.15% H: 4.61% C: 1.91%

trial
Koning Begins FDA Clinical Screening Trial in Daytona Beach, Florida
Published: 2021-11-01 (Crawled : 15:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

fda trial
ElectraMeccanica Strategic Partner Zongshen Industrial Group Validates Company’s Go Forward Strategy With The Exercise of 1.4 Million Warrants
Published: 2021-11-01 (Crawled : 13:00) - globenewswire.com
SOLO | $0.2122 1.37% 440K twitter stocktwits trandingview |
Consumer Durables
| | O: 1.97% H: 0.0% C: 0.0%

trial
Acurx Announces New Microbiome Data from Its Phase 2a Clinical Trial of Ibezapolstat for CDI at the 9th International C. diff. Conference
Published: 2021-11-01 (Crawled : 12:00) - prnewswire.com
ACXP | $2.04 -2.29% 17K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.2% H: 11.38% C: 9.18%

phase 2 trial conference phase 2b
Hyster-Yale Materials Handling, Inc. To Participate In Baird Virtual Global Industrial Conference
Published: 2021-11-01 (Crawled : 11:00) - prnewswire.com
GIC | $40.96 -0.82% 0.0% 57K twitter stocktwits trandingview |
Retail Trade
| | O: -1.11% H: 0.0% C: 0.0%
HY 4 | $60.84 -1.25% 0.0% 62K twitter stocktwits trandingview |
Producer Manufacturing
| | O: 0.65% H: 5.54% C: 2.9%

trial conference
Eurotech Recognized in the 2021 Gartner® Magic Quadrant™ for Industrial IoT Platforms
Published: 2021-11-01 (Crawled : 08:00) - prnewswire.com
IT | $451.06 0.18% 0.0% 280K twitter stocktwits trandingview |
Commercial Services
| | O: 0.24% H: 0.0% C: 0.0%

iot platform trial
DBV Technologies to Highlight New Long-term Data from REALISE Trial at ACAAI 2021
Published: 2021-11-01 (Crawled : 07:00) - globenewswire.com
DBVT | $0.68 3.98% 2.6K twitter stocktwits trandingview |
Health Technology
| | O: 11.88% H: 0.0% C: -4.13%

trial
HUTCHMED and AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in Combination with PD-L1 Inhibitor IMFINZI® in Patients with MET-Driven Advanced Papillary Renal Cell Carcinoma
Published: 2021-11-01 (Crawled : 06:00) - globenewswire.com
AZNCF | News | $140.3 -4.19% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 1.7% C: 1.64%
HCM | $18.405 0.85% 0.84% 58K twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 3.03% C: 2.38%
AZN | News | $71.175 0.46% 0.46% 6.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.3% H: 0.95% C: 0.43%

renal trial cell carcinoma
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.